Clinical trial
Nicotinamide Riboside to Improve Functioning in PAD
NCT07782671 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotinamide Riboside to Improve Functioning in PAD
- Lead sponsor
- Northwestern University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- July 31, 2031
- Enrollment
- 250 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease (pad)